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background: The purpose of this study was to evaluate the efficacy of adding Ivabradine to β-blockers during cardiac rehabilitation in patients 
with recent coronary artery bypass (CAB).
methods: Between June 2012 and June 2013, 81 out of 150 patients, admitted at our Cardiac Rehabilitation Unit after a median interval time of 
10 days from CAB, were scheduled for this prospective randomized study according to the following criteria: normal LVEF, sinus rhythm, heart rate 
>70 bpm, stable clinical condition.
The patients were randomized into two groups: Group I (n=38): Ivabradine (5 mg bid) + β-blocker (bisoprolol 1.25 mg od) and Group B (n=43): 
β-blocker (bisoprolol 2.5-5mg od). All the patients were evaluated at admission, discharge, and after 3 months of follow-up.
results: The ejection fraction improved significantly in Group I, both at discharge and follow-up. In Group I, patients showed a significantly 
impaired functional status at 6-minute walking test (6MWT), that improved during cardiac rehabilitation and at follow up; the percentage 
improvement of distance during 6MWT was significantly higher in Group I (55% vs 42% after 3 months). Finally, the rate of diastolic dysfunction 
increased significantly in Group B, but decreased significantly in Group I.
conclusion: In patients submitted to recent CAB, adding Ivabradine to low dose of β-blockers, throughout cardiac rehabilitation, might improve 
the recovery of systolic function and exercise capacity, and reduce the rate of diastolic dysfunction.
Table 1 Baseline Discharge Follow-up
I B I B I B
LV ejection fraction (%) 57±3 57±3 59±4 62±4* 59±4 66±3*
6MWT (meters) 215±53 180±91* 314±32 311±58 347±42 370±55
Diastolic dysfunction
Grade I 63% 58% 50% 63%* 21% 77%*
Grade II 13% 19% 0 19%* 0 7%*
∆ (baseline-discharge) ∆ (discharge-follow up) ∆ (baseline-follow up)
∆ Covered distance (%) 120 (80-170) 100 (80-130) 40 (8-88) 40 (0-60) 170 (130-235) 135 (80-177) *
